Clinical Trials on Opportunistic Infections, HIV Related

Total 11568 results

National Institute of Allergy and Infectious Diseases...
GlaxoSmithKline; Bill and Melinda Gates Foundation; Medical Research Council; Sanofi... and other collaborators

Completed

A Safety and Immune Response Study of 2 Experimental HIV Vaccines

HIV Infection

South Africa
National Institute of Allergy and Infectious Diseases...
AIDS Clinical Trials Group; HIV Prevention Trials Network

Completed

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in At-Risk Men Who Have Sex With Men and in At-Risk Women

HIV Infection

United States, Puerto Rico
Icahn School of Medicine at Mount Sinai
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Targeting Platelets in Chronic HIV Infection

HIV-1 Infection

United States
Bristol-Myers Squibb

No longer available

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

HIV Infection

United States, Puerto Rico
PENTA Foundation

Completed

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children (PENTA 13)

HIV Infection

United Kingdom
407 Doctors
Bristol-Myers Squibb; Merck Sharp & Dohme LLC

Unknown

Once Daily 3TC, Efavirenz and ddI for HIV Infection

HIV Infection | AIDS

Australia
Assistance Publique - Hôpitaux de Paris

Completed

Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients (IGRAVIH)

HIV | Tuberculosis | Latent Tuberculosis Infection

France
ANRS, Emerging Infectious Diseases
University Hospital, Grenoble; Hopital Antoine Beclere; Dr Yassine Taoufik Dr... and other collaborators

Completed

Cohort of HIV Associated Lymphomas (ANRS CO16)

HIV Infection

France
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China

HIV Infections | Opiate Dependence

China, United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Withdrawn

Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India (DAART+)

HIV Infections | Heroin Dependence

India
Catholic University of Pelotas

Completed

Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis Catheters (CITRIM)

Catheter Related Infection
Mahidol University

Recruiting

Early Versus Conventional Cessation of Hydrocortisone in Septic Shock (CESSHYDRO)

Hyperglycemia | Septic Shock | Muscle Weakness | Hypernatremia | Adverse Event | Hydrocortisone | Superimposed Infection

Thailand
Butler Hospital
National Institute of Mental Health (NIMH)

Completed

Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users

Substance-Related Disorders | Depression | HIV Infections

United States
The Alfred
National Health and Medical Research Council, Australia; Monash University

Withdrawn

Predictors of Drug Hypersensitivity in HIV Infected Subjects

HIV Infections | Hypersensitivity

Australia
University of Washington
La Clinique des Maladies Infectieuses, Centre Hospitalier National Universitaire...

Completed

Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa

HIV and Tuberculosis Co-infection
ANRS, Emerging Infectious Diseases

Unknown

Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection (RIFAVIRENZ)

HIV | Tuberculosis

Uganda
Yale University
Robert Wood Johnson Foundation

Completed

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence (Project RED)

HIV Infections | Opiate Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Directly Administered HIV Therapy in Methadone Clinics

HIV Infections | Heroin Dependence

United States
Oregon Health and Science University
Hanoi Medical University; Hennepin Healthcare Research Institute

Completed

Buprenorphine to Improve HIV Care Engagement and Outcomes (BRAVO)

HIV | Substance Related Disorders

Vietnam
University of Pennsylvania
National Institute on Drug Abuse (NIDA); Peter F. McManus Charitable Trust; National...

Completed

Yoga Intervention for Substance Use and ART Adherence in Community Reentry

HIV | Substance Related Disorders

United States
Capital Medical University

Unknown

The Standard Management of HPV Infection

the High-Risk HPV Infection

China
Columbia University
National Institute on Drug Abuse (NIDA)

Completed

Increasing MSM in the Continuum of Care in Kazakhstan

Substance-Related Disorders | HIV

United States, Kazakhstan
Fondazione Penta UK
UCL Great Ormond Street Institute of Child Health

Recruiting

Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

HIV Infections

Spain, Switzerland, United Kingdom, Belgium, Italy, Romania, Russian Federation
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Completed

Love Infection: A Dramatized Story Intervention (Telenovela/Soap Opera) for HIV Prevention (IA)

HIV Infections

United States
HIV Vaccine Trials Network

Completed

An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials

HIV Infections

United States, Dominican Republic, Haiti, Peru, Puerto Rico, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at Risk of Acquiring HIV-1 Infection

HIV Infections

United States, Thailand, Puerto Rico, Brazil, South Africa
National Institute of Allergy and Infectious Diseases...

Terminated

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

HIV Infections

United States
CytoDyn, Inc.
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

PRO 140 by IV Administration in Adults With HIV-1 Infection

HIV Infections

United States
Boehringer Ingelheim

Completed

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

HIV Infections

Germany
Immunobiology Research Institute

Completed

Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection

HIV Infections

United States
Arizona State University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); San Diego State... and other collaborators

Recruiting

Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention

Alcohol Use Disorder | Domestic Violence | Intimate Partner Violence | HIV-infection/Aids

Uganda
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Brief Introductory Therapy for Opioid Dependence

HIV Infections | Opiate Dependence

United States
Organization to Achieve Solutions in Substance...

Unknown

Integrating Buprenorphine Into HIV Treatment

HIV Infections | Opiate Dependence

United States
GlaxoSmithKline

Completed

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

HIV Infection | Infection, Human Immunodeficiency Virus

United States, Belgium, France, Germany, Spain, Canada, Italy, Portugal, Romania, Austria, Switzerland, Poland, Latvia, Luxembourg
Hospital Nossa Senhora da Conceicao

Unknown

Catheter Early Withdrawal or Maintenance in Sepsis or Septic Shock

Catheter Related Infection

Brazil
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

HIV Infections

United States, Kenya, South Africa, Thailand
National Institute of Allergy and Infectious Diseases...

Completed

A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Celgene Corporation

Completed

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

HIV Infections

United States
University of Wisconsin, Madison
Agouron Pharmaceuticals

Completed

Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection

HIV Infections

United States
Fundacion SEIMC-GESIDA

Completed

Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection (KIRAL)

HIV Infections

Spain
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection (VIRECURE)

HIV Infections

Spain
Boehringer Ingelheim

Completed

A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.

HIV Infections

Romania
French National Agency for Research on AIDS and...
Institut Pasteur; University of Paris 5 - Rene Descartes; Hôpital Necker-Enfants...

Completed

Immunology of the Infection Perinatal (EP38)

HIV Infections
Glaxo Wellcome

Completed

An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen

HIV Infections

United States
PDS Biotechnology Corp.

Completed

An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

High-risk HPV Infection and Biopsy-proven CIN1

United States
Vir Biotechnology, Inc.
Bill and Melinda Gates Foundation

Completed

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

HIV I Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women

HIV Infections

South Africa, Zimbabwe, Malawi, Botswana, Kenya, Mozambique, Tanzania
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men

HIV Infections

United States, Peru, Brazil, Switzerland
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Glaxo Wellcome

Completed

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

HIV Infections

United States
Boehringer Ingelheim

Approved for marketing

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

HIV Infections

Belgium, Brazil, Canada, Denmark, El Salvador, Greece, Italy, Portugal, Spain

Clinical Trials on Opportunistic Infections, HIV Related

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations